Reijiro Arakawa

779 total citations
11 papers, 684 citations indexed

About

Reijiro Arakawa is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Reijiro Arakawa has authored 11 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 9 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Reijiro Arakawa's work include Cholesterol and Lipid Metabolism (9 papers), Drug Transport and Resistance Mechanisms (7 papers) and Peroxisome Proliferator-Activated Receptors (7 papers). Reijiro Arakawa is often cited by papers focused on Cholesterol and Lipid Metabolism (9 papers), Drug Transport and Resistance Mechanisms (7 papers) and Peroxisome Proliferator-Activated Receptors (7 papers). Reijiro Arakawa collaborates with scholars based in Japan and United States. Reijiro Arakawa's co-authors include Shinji Yokoyama, Sumiko Abe-Dohmae, Noriyuki Iwamoto, Kazumitsu Ueda, Rui Lu, Norimasa Tamehiro, Tomoko Nishimaki‐Mogami, Jin‐ichi Ito, Arowu R. Tanaka and Michi Hayashi and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Reijiro Arakawa

11 papers receiving 677 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reijiro Arakawa Japan 9 576 417 356 99 98 11 684
Yuika Ikeda Japan 9 408 0.7× 366 0.9× 327 0.9× 95 1.0× 58 0.6× 13 668
Michi Hayashi Japan 7 432 0.8× 342 0.8× 281 0.8× 92 0.9× 54 0.6× 7 565
Catherine L. Knapper United States 9 576 1.0× 413 1.0× 316 0.9× 80 0.8× 118 1.2× 10 795
Hansook Kim Chong United States 9 213 0.4× 326 0.8× 156 0.4× 59 0.6× 139 1.4× 11 671
Seth M. Klein United States 6 455 0.8× 355 0.9× 173 0.5× 42 0.4× 132 1.3× 7 685
Keith Fichter Canada 3 254 0.4× 198 0.5× 162 0.5× 43 0.4× 48 0.5× 3 377
Chris Daige United States 6 744 1.3× 538 1.3× 440 1.2× 81 0.8× 198 2.0× 8 1.0k
Mehrdad Haghpassand United States 12 832 1.4× 588 1.4× 374 1.1× 125 1.3× 229 2.3× 14 1.1k
Tadashi Koieyama Japan 6 360 0.6× 230 0.6× 175 0.5× 36 0.4× 99 1.0× 7 422
Amir Babiker Sweden 11 671 1.2× 464 1.1× 269 0.8× 75 0.8× 105 1.1× 12 857

Countries citing papers authored by Reijiro Arakawa

Since Specialization
Citations

This map shows the geographic impact of Reijiro Arakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reijiro Arakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reijiro Arakawa more than expected).

Fields of papers citing papers by Reijiro Arakawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reijiro Arakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reijiro Arakawa. The network helps show where Reijiro Arakawa may publish in the future.

Co-authorship network of co-authors of Reijiro Arakawa

This figure shows the co-authorship network connecting the top 25 collaborators of Reijiro Arakawa. A scholar is included among the top collaborators of Reijiro Arakawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reijiro Arakawa. Reijiro Arakawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Masuda, Tomomi, Yūji Takahashi, Ayako Suzuki, et al.. (2022). Effect of triamcinolone acetonide on retinal inflammation and angiogenesis induced by pericyte depletion in mouse. Journal of Pharmacological Sciences. 151(1). 28–36. 3 indexed citations
2.
Suzuki, Ayako, Mayumi Takata, Takashi Kurasawa, et al.. (2020). Comparative study on pharmacokinetics and toxicity of intravitreal and sub-Tenon injection of triamcinolone acetonide in ocular tissues. International Journal of Ophthalmology. 13(12). 1864–1871. 4 indexed citations
3.
Yokoyama, Shinji, Reijiro Arakawa, Noriyuki Iwamoto, et al.. (2011). Calpain-mediated ABCA1 degradation: Post-translational regulation of ABCA1 for HDL biogenesis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1821(3). 547–551. 40 indexed citations
4.
Arakawa, Reijiro, Maki Tsujita, Noriyuki Iwamoto, et al.. (2009). Pharmacological inhibition of ABCA1 degradation increases HDL biogenesis and exhibits antiatherogenesis. Journal of Lipid Research. 50(11). 2299–2305. 43 indexed citations
5.
Lu, Rui, et al.. (2008). ApoA-I Facilitates ABCA1 Recycle/Accumulation to Cell Surface by Inhibiting Its Intracellular Degradation and Increases HDL Generation. Arteriosclerosis Thrombosis and Vascular Biology. 28(10). 1820–1824. 74 indexed citations
6.
Arakawa, Reijiro, Norimasa Tamehiro, Tomoko Nishimaki‐Mogami, Kazumitsu Ueda, & Shinji Yokoyama. (2005). Fenofibric Acid, an Active Form of Fenofibrate, Increases Apolipoprotein A-I–Mediated High-Density Lipoprotein Biogenesis by Enhancing Transcription of ATP-Binding Cassette Transporter A1 Gene in a Liver X Receptor–Dependent Manner. Arteriosclerosis Thrombosis and Vascular Biology. 25(6). 1193–1197. 64 indexed citations
7.
Arakawa, Reijiro, Michi Hayashi, Alan T. Remaley, et al.. (2004). Phosphorylation and Stabilization of ATP Binding Cassette Transporter A1 by Synthetic Amphiphilic Helical Peptides. Journal of Biological Chemistry. 279(8). 6217–6220. 66 indexed citations
8.
Suzuki, Shogo, Tomoko Nishimaki‐Mogami, Norimasa Tamehiro, et al.. (2004). Verapamil Increases the Apolipoprotein-Mediated Release of Cellular Cholesterol by Induction of ABCA1 Expression Via Liver X Receptor-Independent Mechanism. Arteriosclerosis Thrombosis and Vascular Biology. 24(3). 519–525. 43 indexed citations
9.
Arakawa, Reijiro & Shinji Yokoyama. (2002). Helical Apolipoproteins Stabilize ATP-binding Cassette Transporter A1 by Protecting It from Thiol Protease-mediated Degradation. Journal of Biological Chemistry. 277(25). 22426–22429. 180 indexed citations
10.
Tanaka, Arowu R., Yuika Ikeda, Sumiko Abe-Dohmae, et al.. (2001). Human ABCA1 Contains a Large Amino-Terminal Extracellular Domain Homologous to an Epitope of Sjögren's Syndrome. Biochemical and Biophysical Research Communications. 283(5). 1019–1025. 82 indexed citations
11.
Arakawa, Reijiro, et al.. (2000). Involvement of caveolin-1 in cholesterol enrichment of high density lipoprotein during its assembly by apolipoprotein and THP-1 cells. Journal of Lipid Research. 41(12). 1952–1962. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026